Clinical Trial Update: Effect of Probiotics "Psychobiotics" on Depression and Metabolic Syndrome in Saudi Arabia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial in Saudi Arabia evaluating the effects of probiotic psychobiotics on depression, anxiety disorders, and metabolic syndrome. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder
• Metabolic Syndrome

Drugs mentioned

• Probiotics (psychobiotics)

Snippet

Sponsor: Roaa Ahmed Alkreadees | Conditions: Depression Anxiety Disorder | Phase 2, Phase 3 | Status: RECRUITING